COMMD5 and cancer: The plot analysis showed that occurrence of COMMD5 amplification is frequently observed in most of cancer types and particularly in breast invasive carcinoma, oesophagus, liver, uterine, and renal cancers, where this amplification correlated with high level of COMMD5 mRNA expression (more than five-fold relative to normal samples).